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Abstract
Introduction
Integrating  one  or  more  public  health  programs  may 
improve the ability of programs to achieve common goals. 
Expanding knowledge on how program integration occurs, 
how it benefits each individual program, and how it con-
tributes to the achievement of common goals is an impor-
tant area of inquiry in public health.
Methods
The  National  Breast  and  Cervical  Cancer  Early 
Detection Program (NBCCEDP) and the Well-Integrated 
Screening and Evaluation for Women Across the Nation 
(WISEWOMAN) program combined data from 10 of their 
overlapping state or tribal programs to calculate preva-
lence estimates of repeat mammography at 18 months. 
The data were stratified by whether women attended the 
combined program or only the NBCCEDP. Logistic regres-
sion analyses were conducted to identify factors that were 
thought to independently contribute to a greater likelihood 
of a woman receiving a repeat mammogram.
Results
Women who participated in both programs were 1.5 to 
5.1 times as likely to be rescreened, depending on pro-
gram  location,  as  women  who  participated  only  in  the 
NBCCEDP.  WISEWOMAN  participants  who  received  a 
follow-up  WISEWOMAN  screening  for  chronic  disease 
risk factors within a year of their initial WISEWOMAN 
screening were 5 times more likely to return for a follow- 
up  mammogram  through  the  NBCCEDP  than  were 
WISEWOMAN participants who did not.
Discussion
Participation  in  both  the  NBCCEDP  and  the 
WISEWOMAN program is associated with a greater like-
lihood of a woman returning for a follow-up mammogram 
within 18 months of her initial examination. Collecting 
more in-depth information on motivational factors and on 
the association between receipt of multiple services and a 
woman’s engagement in a health program should be the 
subject of future research.
Introduction
The Centers for Disease Control and Prevention (CDC) 
provides low-income, uninsured, and underserved women 
access  to  timely,  high-quality  screening  and  diagnostic 
services to detect breast and cervical cancer at the ear-
liest  stages  through  the  National  Breast  and  Cervical 
Cancer Early Detection Program (NBCCEDP) (1). In 1993, 
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Congress authorized CDC to develop a combined approach 
to women’s health by offering heart disease and stroke 
prevention services to women enrolled in the NBCCEDP.
The heart disease and stroke prevention program, later 
named  the  Well-Integrated  Screening  and  Evaluation 
for Women Across the Nation (WISEWOMAN) program, 
was first funded in 1995 (2). Low-income women aged 40 
to 64 years enrolled in the NBCCEDP are qualified for 
WISEWOMAN.
Many  health  interventions  include  testing  for  choles- 
terol, blood glucose, and blood pressure, but WISEWOMAN 
also  provides  lifestyle  intervention  and  referral  ser- 
vices. Through WISEWOMAN, qualified women receive   
chronic disease risk factor screening and health education 
interventions  that  help  them  lower  their  risk  for  heart 
disease.  By  helping  women  adopt  healthy  eating  pat-
terns and encouraging them to be more physically active, 
WISEWOMAN aims to help women know their risk for 
heart disease and develop a heart-healthy lifestyle.
The coordination of these two programs is one example 
of an integrated and comprehensive approach to improving 
the public’s health. The successful implementation of such 
an approach, however, requires comprehensive changes to 
health care systems (3). Understanding how the coordina-
tion of multiple chronic disease programs might enhance 
the effectiveness of each is key to advancing prevention 
efforts. As part of an overall assessment on the benefits of 
combined approaches to preventive health, WISEWOMAN 
and  the  NBCCEDP  are  conducting  analyses  to  explore 
these  relationships.  This  report  describes  the  results  of 
one part of those analyses: a comparison of breast cancer 
rescreening rates among NBCCEDP participants who also 
participated in the WISEWOMAN program with rescreen-
ing rates among NBCCEDP participants who did not.
Methods
NBCCEDP and WISEWOMAN
The  NBCCEDP  is  implemented  through  cooperative 
agreements with grantee programs in all 50 states, the 
District  of  Columbia,  4  territories,  and  13  American 
Indian  and  Alaska  Native  jurisdictions.  WISEWOMAN 
is currently implemented in 13 state health departments 
and 2 tribal organizations. Participation in WISEWOMAN 
is limited to women enrolled in the NBCCEDP, although 
not all eligible NBCCEDP participants choose to partici-
pate in WISEWOMAN, and not all NBCCEDP sites offer 
the WISEWOMAN program.
Twice a year, WISEWOMAN and NBCCEDP grantees 
send a report to CDC on the clinical services provided, 
including data on participant demographics, clinical pro-
cedures  and  outcomes,  and  physiologic  measures.  This 
report is based on data from 10 state or tribal grantees 
that  implemented  both  WISEWOMAN  and  NBCCEDP 
and  had  enough  participants  during  the  study  period 
to  produce  stable  estimates  of  follow-up  mammography 
screening rates. 
From 2000  to  2004,  17%  of NBCCEDP  participants 
at  the  10  grantee  locations  (range,  8%–39%)  were also   
enrolled in WISEWOMAN. The study cohort consisted of 
women enrolled in the NBCCEDP from January 1, 2000 
(the date of the first WISEWOMAN screening) through 
June 30, 2003. Women who had a normal result on an ini-
tial mammography screening during this period were fol-
lowed for 18 months to determine whether they received a 
routine rescreening mammogram through the NBCCEDP. 
A woman was considered to be a participant in both pro-
grams if she received a WISEWOMAN disease risk fac-
tor screening within 18 months of her initial NBCCEDP 
mammography screening.
Rescreening rates for each of the 10 grantee locations 
were weighted by each location’s sample size to produce 
an  overall  estimate  of  NBCCEDP  rescreening  rates  by 
WISEWOMAN participation. A fully adjusted model was 
used to control for demographic characteristics that may be 
associated with rescreening rates (4,5), such as age, race/
ethnicity,  and  program  location.  An  additional  analysis 
of NBCCEDP rescreening rates among women who par-
ticipated in both WISEWOMAN and the NBCCEDP also 
controlled for characteristics including education, baseline 
health  status,  participation  in  WISEWOMAN  lifestyle 
interventions, and whether they had been rescreened for 
chronic  disease  risk  factors  through  the  WISEWOMAN 
program  within  a  year  of  their  initial  WISEWOMAN 
chronic disease risk factors screening.
The first analytic cohort consisted of 68,522 individuals 
who received a baseline mammogram during the enroll-
ment period.
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Across  all  10  programs,  participation  in  both 
WISEWOMAN and the NBCCEDP was associated with 
a  higher  percentage  of  follow-up  mammograms,  with   
adjusted  odds  ratios  ranging  from  1.5  to  5.1  (Table  1). 
Overall, women who participated in both the NBCCEDP 
and  the  WISEWOMAN  program  were  2.8  times  more 
likely to have received a follow-up mammogram than were 
women who participated in the NBCCEDP alone (Table 
2).  The  demographic  characteristics  associated  with  an 
adjusted greater likelihood of having had a repeat mam-
mogram  were  being  aged  50  or  older  and  being  white 
(Table 2).
Among  the  13,742  women  who  participated  in  both 
programs, certain characteristics increased the likelihood 
that women received a follow-up mammography screening. 
Rescreening rates were significantly higher among those 
older than 49 years. American Indian or Alaska Native 
women and women of unknown races had higher rates than 
did  whites,  blacks,  Hispanics,  and  Asians.  Nonsmokers 
were  more  likely  to  be  rescreened  than  were  smokers. 
Those  who  received  follow-up  WISEWOMAN  screen-
ing services within a year of their initial WISEWOMAN 
screening  were  more  likely  than  those  who  did  not  to 
receive a mammography rescreening (Table 3). Adjusted 
results  indicate  that  WISEWOMAN  participants  who 
received  a  follow-up  WISEWOMAN  screening  within  a 
year of their initial WISEWOMAN screening were 5 times 
more likely to return for a follow-up NBCCEDP mammo-
gram than were WISEWOMAN participants who did not.
Discussion
Excluding nonmelanoma skin cancer, breast cancer is 
the most common form of cancer among U.S. women, and 
it accounts for a third of newly diagnosed cancer cases 
among women each year (6). Although appropriate pre-
ventive services, including mammography screening, have 
been shown to reduce the number of cancer deaths (7), 
mammography screening is underused (7,8). Estimates of 
the percentage of women who have undergone mammog-
raphy screening range from 32% to 91%, while estimates 
of the percentage that have undergone rescreening range 
from 28% to 92% (4,9). However, estimated screening rates 
are substantially lower among financially disadvantaged 
populations, such as those served by the NBCCEDP and 
WISEWOMAN (4,5). In an NBCCEDP study of rescreen-
ing rates at selected sites (which reflected rescreenings 
that program participants reported receiving outside the 
NBCCEDP  as  well  as  program-delivered  rescreenings), 
average rates were as high as 72.4% after 18 months and 
81.5% after 30 months; however, rescreening rates were 
lower in the most disadvantaged populations — women 
who were older, were of racial/ethnic minorities, and had 
lower levels of education (9).
Although the rescreening rates among women in this 
cohort who were older, white, American Indian or Alaska 
Native, or WISEWOMAN participants are encouraging, 
the overall results show that practices and strategies to 
increase  rescreening  rates  among  underserved  women 
need  to  be  developed.  The  chances  that  a  patient  will 
follow cancer screening recommendations are influenced 
both by personal factors and by the patient’s health care 
environment. Thus, understanding the interplay of these 
factors is critical for the development of effective cancer 
prevention programs (3).
Joint  participation  in  the  NBCCEDP  and  the 
WISEWOMAN programs may be associated with higher 
cancer rescreening rates for at least three reasons. First, 
women  in  the  NBCCEDP  who  choose  to   participate 
also in WISEWOMAN are likely to be more committed 
to  their  overall  health  care  than  those  who  choose  not 
to  participate  (3).  Second,  women  participating  in  both 
WISEWOMAN  and  the  NBCCEDP  may  feel  that  they 
are  receiving  better,  more  comprehensive  health  care 
service  and  thus  be  more  likely  to  return  for  follow-up 
screening as recommended (3,10). Finally, in addition to 
receiving  annual  reminders  from  the  NBCCEDP  about 
the importance of regular screenings for breast and cervi-
cal cancer, women who also participate in WISEWOMAN 
receive  comprehensive  cardiovascular  disease  screening 
and a series of culturally sensitive lifestyle interventions 
that provide additional contact with health care provid-
ers (10). In effect, WISEWOMAN reminder practices and 
multicomponent  interventions  may  serve  to  reinforce 
the  rescreening  reminders  that  NBCCEDP  participants 
receive, resulting in at least a doubling of the number of 
times that participants are prompted to be rescreened, a 
factor that might be critical for financially disadvantaged 
populations.
Findings from other studies also indicate that coordi-
nated  health  care  efforts  have  a  synergistic  effect.  For 
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example,  in  a  meta-analysis,  researchers  found  that 
interventions designed to increase older women’s access to 
health care were more effective when used in conjunction 
with promotional strategies directed at individuals than 
access-enhancing strategies alone (11).
The findings in this report are subject to several limi-
tations. The sample sizes for the variables listed in the 
tables  differ  because  of  missing  data;  however,  miss-
ing  data  should  have  had  little  effect  on  the  estimates   
presented  here,  given  that  the  demographic  profile  of 
participants  with  missing  data  was  not  significantly 
different  from  that  of  participants  with  complete  data. 
Mammography  screening  guidelines  recommend  annual 
or biennial screening for women aged 40 or older, whereas 
the rescreening rates reported here are based on a follow-
up period of 18 months. Another limitation is that this 
study did not capture rescreening that NBCCEDP partici-
pants may have undergone outside of the NBCCEDP, nor 
did it adjust for differences in participants’ mammography 
screening history or for the timeliness of historical screen-
ings; these are all characteristics that might indicate other 
sources of funding for mammograms, as well as secular 
trends. Finally, women who are highly health-conscious 
may be more likely to participate in both WISEWOMAN 
and  NBCCEDP  and  may  be  more  likely  to  return  for 
NBCCEDP rescreening.
Overcoming this self-selection bias in future NBCCEDP/
WISEWOMAN  studies  will  be  difficult  because,  if  the 
programs are fully integrated, women will have no choice 
but to attend both, effectively ensuring that motivation is 
not the key factor in attending. Thus, researchers will be 
unable to compare rescreening rates of women who attend 
both programs with the rates of those who attend only 
one program. Measuring health motivation and ensuring 
that all study participants are equally motivated might 
be another way to address this issue of self-selection bias. 
However,  neither  program  currently  has  a  measure  of 
health motivation. Thus, the data provided in this study 
are the strongest available for these two programs.  
The results of this analysis suggest that participation in 
both the NBCCEDP and WISEWOMAN may result in bet-
ter adherence to mammography rescreening recommenda-
tions. A number of likely explanations for these results 
have been proposed: women who receive multiple services 
may be more invested in the program or, alternatively, 
women who are more health-conscious may be likely to 
select a more intensive combined program. Consequently, 
further research is needed to better understand the rea-
sons behind these findings.
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Tables
Table 1. NBCCEDP Participants Who Underwent Follow-up Mammography Screening Within 18 Months of Their Initial 
Mammogram, by Program Location and Participation in the WISEWOMAN Program, and the Increased Likelihood of 
Rescreening Associated with WISEWOMAN Participation, 2000–2004
Location Program No. Participants
Mammography
Rescreened, %
Unadjusted 
OR (95% CI) Adjusteda OR (95% CI)
A   NBCCEDP only 4,01 42 Ref Ref
NBCCEDP + WW 898 64 2. (2.18-2.94) 2.44 (2.09-2.86)
B NBCCEDP alone 1,94  Ref Ref
NBCCEDP + WW 48 80 . (2.77-4.) .6 (2.61-4.4)
C NBCCEDP alone 14,119 27 Ref Ref
NBCCEDP + WW 4,101 2 .01 (2.81-.24) 2.90 (2.69-.12)
D NBCCEDP alone 16,09 1 Ref Ref
NBCCEDP + WW 1,411 4 2.7 (2.1-2.87) 2.61 (2.0-2.96)
E NBCCEDP alone ,21 29 Ref Ref
NBCCEDP + WW ,90 67 .11 (4.60-.68) .09 (4.8-.66)
F NBCCEDP alone 9,87 7 Ref Ref
NBCCEDP + WW 2,08 47 1.2 (1.8-1.67) 1.49 (1.-1.64)
G NBCCEDP alone 60 24 Ref Ref
NBCCEDP + WW 19  .84 (2.87-.12) .84 (2.84-.18)
H NBCCEDP alone 788 41 Ref Ref
NBCCEDP + WW 27  1.78 (1.7-2.0) 1.68 (1.29-2.21)
I NBCCEDP alone ,066 1 Ref Ref
NBCCEDP + WW 461 67 2.01 (1.6-2.47) 1.9 (1.7-2.8)
J NBCCEDP alone 1,04 4 Ref Ref
NBCCEDP + WW 9 62 .06 (2.8-.94) .08 (2.9-.97)
 
NBCCEDP indicates National Breast and Cervical Cancer Early Detection Program; WW, WISEWOMAN program; OR, odds ratio; CI, confidence interval; Ref, 
referent group. 
a Adjusted for age and race/ethnicity.
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Mammograms and Their Relative Likelihood of Doing So, by WISEWOMAN Participation, Age, and Race/Ethnicity, 2000–
2004
Characteristic No. Participantsa
Mammography
Rescreened, %
Unadjusted 
OR (95% CI)
Adjustedb 
OR (95% CI)
Program
NBCCEDP alone 4,780 4  Ref Ref
NBCCEDP + WW 1,742 8 2.71 (2.61-2.82) 2.7 (2.60-2.82)
Age, y
40-49 0,614 28 Ref Ref
0-9 0,000 46 2.1 (2.0-2.20) 2.14 (2.06-2.22)
≥60 7,767 2 2.71 (2.7-2.8) 2.78 (2.64-2.9)
Race/ethnicity
White 9,79 41 Ref Ref
Black 10,04  0.70 (0.67-0.7) 0.76 (0.72-0.80)
Hispanic 9,1 4 0.7 (0.72-0.79) 0.88 (0.8-0.92)
Asianc 1,866 28 0.7 (0.1-0.6) 0.6 (0.8-0.72)
American Indian or Alaska Native ,1 46 1.2 (1.18-1.) 0.6 (0.6-0.72)
Unknown 1,709  0.79 (0.71-0.87) 0.71 (0.6-0.79)
 
NBCCEDP indicates National Breast and Cervical Cancer Early Detection Program; WW, WISEWOMAN program; OR, odds ratio; CI, confidence interval; Ref, 
referent group. 
a Participant totals differ because of missing data. 
b Adjusted for participation at individual locations and in the WISEWOMAN program, and for age and race/ethnicity. 
c Included women who identified themselves as Native Hawaiian or other Pacific Islander. 
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Table 3. Percentage of Participants in Both the NBCCEDP and the WISEWOMAN Program Who Underwent Follow-up 
Mammography Screening Within 18 Months of Their Initial Mammograms and Their Relative Likelihood of Doing So, by 
Participant Characteristics, 2000–2004
Characteristic No. Participantsa
Mammography
Rescreened, %
Unadjusted 
OR (95% CI)
Adjustedb 
OR (95% CI)
Sociodemographics
Age, y
40-49 ,781 49 Ref Ref
0-9 6,4 64 1.81 (1.68-1.94) 1.88 (1.72-2.06)
≥60 1,87 69 2. (2.07-2.6) 2.1 (1.84-2.46)
Education
Less than high school 1,42 9 0.86 (0.76-0.97) 0.90 (0.77-1.0)
Some high school 1,04 9 0.86 (0.76-0.97) 0.86 (0.7-0.98)
High school graduate ,422 6 Ref Ref
Some college or more 4,08 6 0.77 (0.71-0.84) 0.76 (0.69-0.8)
Race/ethnicity
White 9,096 9 Ref  Ref
Black 1,0  0.77 (0.69-0.87) 0.82 (0.71-0.94)
Hispanic 1,881 8 0.94 (0.8-1.04) 0.91 (0.79-1.04)
Asianc 402 46 0.60 (0.49-0.7) 0.68 (0.2-0.89)
AI or AN 781 61 1.10 (0.94-1.27) 1.27 (1.07-1.2)
Unknown 22 67 1.42 (1.09-1.8) 1.4 (1.0-1.9)
Baseline health status
Smoking
No 10,268 61 Ref Ref
Yes ,19 1 0.67 (0.61-0.72) 0.67 (0.61-0.74)
Diabetes
No 12,429 8 Ref Ref
Yes 1,10 8 1.00 (0.89-1.12) 0.91 (0.79-1.0)
Hypertension
No 8,266 7 Ref Ref
Yes 4,768 60 1.16 (1.08-1.2) 1.00 (0.91-1.10)
High cholesterol
No 9,179 7 Ref Ref
Yes ,814 60 1.1 (1.0-1.22) 0.9 (0.86-1.04)
Body mass index
<2.0 ,490  Ref Ref
2.0-29.9 ,829 60 1.20 (1.10-1.2) 1.08 (0.97-1.20)
≥30.0 ,20 8 1.12 (1.0-1.22) 1.00 (0.90-1.11)
8  Centers for Disease Control and Prevention • www.cdc.gov/pcd/issues/2007/oct/06_0126.htm
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NBCCEDP, National Breast and Cervical Cancer Early Detection Program; WW, WISEWOMAN program; OR, odds ratio; CI, confidence interval; AI, American 
Indian; AN, Alaska Native; Ref, referent group. 
a Participant totals by characteristics differ because of missing data. 
b Adjusted for all variables listed in the table, including WISEWOMAN rescreening. 
c Included women who identified themselves as Native Hawaiian or other Pacific Islander.
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Characteristic No. Participantsa
Mammography
Rescreened, %
Unadjusted 
OR (95% CI)
Adjustedb 
OR (95% CI)
WISEWOMAN characteristics
Lifestyle intervention attendance
Zero sessions 4,098 7 Ref Ref
One or more sessions 9,644 8 1.06 (0.98-1.14) 1.09 (1.00-1.20)
WISEWOMAN rescreening at 10-14 months
No 9,8 47 Ref Ref
Yes 4,7 81 4.8 (4.44-.27) .02 (4.2-.7)
 
NBCCEDP, National Breast and Cervical Cancer Early Detection Program; WW, WISEWOMAN program; OR, odds ratio; CI, confidence interval; AI, American 
Indian; AN, Alaska Native; Ref, referent group. 
a Participant totals by characteristics differ because of missing data. 
b Adjusted for all variables listed in the table, including WISEWOMAN rescreening. 
c Included women who identified themselves as Native Hawaiian or other Pacific Islander.
Table 3. (continued) Percentage of Participants in Both the NBCCEDP and the WISEWOMAN Program Who Underwent Follow-
up Mammography Screening Within 18 Months of Their Initial Mammograms and Their Relative Likelihood of Doing So, by 
Participant Characteristics, 2000–2004